Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Moneerah J. Alqahtani has a total of 119 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Phytochemical Profile and Bioactivities of Elaeagnus angustifolia Seeds: Antioxidant, Antibacterial, and In Silico Evaluation

    by El‐Assri Youssef, El‐Assri El‐Mehdi, Sofia Zazouli, Boukour Sara, Oussama Khibech, Moneerah J. Alqahtani, Jawaher H. Alqahtani, Joe Miantezila Basilua, Eloutassi Noureddine, Laglaoui Amin, et al.

    The present study examined the phytochemical composition, antioxidant, antibacterial, and in silico properties of Elaeagnus angustifolia seed extracts. Methanol and ethanol extracts exhibited the highest yields (7.22% and 4.63%), reflecting the predominance of polar constituents. HPLC‐PDA identified forty‐three compounds, including phenolic acids, flavonoids, proanthocyanidins, alkaloids, and triterpenoids, several of which were reported in seeds for the first time. Both extracts showed antibacterial activity against Gram‐positive and Gram‐negative bacteria (MICs 3.5–30 mg/mL) and inhibited biofilm formation in Escherichia coli , Salmonella typhimurium , and Bacillus subtilis . Antioxidant assays showed strong radical‐scavenging activity (IC 50 = 0.184–0.211 mg/mL) and high total antioxidant capacity (154.86 mg AAE/g for methanol; 124.81 mg AAE/g for ethanol). In silico analysis showed that ethanolic constituents exhibited higher lipophilicity and membrane permeability, whereas methanolic compounds were more polar, water‐soluble, and safer. Molecular docking revealed stronger and more consistent binding interactions of ethanolic compounds toward bacterial targets, while caffeic acid showed the most promising profile among methanolic compounds. ProTox‐III analysis indicated compound‐dependent differences in predicted acute oral toxicity. These predictions are preliminary and require experimental toxicological validation. This study provides comprehensive chemical and in silico characterization of Elaeagnus angustifolia seed extracts, supporting future antibacterial and antioxidant applications and guiding further experimental investigations.

  • Open Access

    Multiscale Computational Prioritization of Chromone-Based Acetylcholinesterase Ligands

    by Oussama Khibech, Bahia Abdelfattah, Mohamed Bouhrim, Moneerah J. Alqahtani, Jawaher H. Alqahtani, Joe Miantezila Basilua, Aziz Boulouiz, Rachid Touzani

    Identifying acetylcholinesterase (AChE) ligands for Alzheimer’s disease research requires integrating molecular recognition with pharmacokinetic and safety considerations. Here, four designed chromone derivatives (M1–M4) were investigated to determine how conformational sampling and complementary molecular descriptors refine docking-based prioritization. Donepezil redocking in human AChE and cross-docking into Torpedo californica AChE recovered the crystallographic and transferred reference orientations, respectively, with RMSDs of 0.942 and 1.074 Å. Molecular docking was integrated with 800 ns molecular dynamics, MM/PBSA, electronic-structure calculations, and pharmacokinetic/toxicity predictions. M4 achieved the most favorable chromone docking score (−9.6 kcal mol−1), whereas M3 yielded the most favorable chromone MM/PBSA estimate within the 775–800 ns window (−23.90 ± 2.31 kcal mol−1). Donepezil retained a more favorable MM/PBSA estimate (−41.00 ± 2.75 kcal mol−1). M4 exhibited the highest electronic hardness, while predicted toxicity profiles revealed distinct liabilities across the series. The divergence between docking and sampled energetics highlights the value of integrating complementary criteria when selecting compounds for experimental evaluation. These protocol-dependent findings prioritize M3 and M4 as complementary computational candidates requiring experimental confirmation of AChE inhibition, selectivity, and safety.

  • Open Access

    Phenolic Profiling and OECD-Guided Acute and Subacute Oral Toxicity Assessment of Cannabis sativa L. Seed Hydroethanolic Extract

    by Rafik El-Mernissi, Naoual El Menyiy, Aziz Zouhri, Yahya El-Mernissi, Ghizlane Nouioura, Mohamed Bouhrim, Moneerah J. Alqahtani, Jawaher H. Alqahtani, Joe Miantezila Basilua, Nadia Senhaji, et al.

    Cannabis sativa L. seeds have been traditionally used in Moroccan folk medicine and are increasingly recognized as a valuable source of nutrients and bioactive phytochemicals with promising therapeutic properties. Despite their widespread traditional and nutritional use, scientific evidence supporting their toxicological safety remains limited. This study aimed to characterize the phenolic profile of a hydroethanolic extract of Cannabis sativa L. seeds and to evaluate its acute and 28-day repeated-dose oral toxicity in mice following the Organization for Economic Cooperation and Development (OECD) guidelines. The phenolic composition of the extract was analyzed using high-performance liquid chromatography coupled with diode-array detection (HPLC-DAD). Acute oral toxicity was assessed according to OECD Guideline 423 after a single oral administration of 5000 mg/kg body weight. Repeated-dose oral toxicity was evaluated following OECD Guideline 407 by administering the extract orally at doses of 500 and 1000 mg/kg/day for 28 consecutive days. Clinical observations, body weight, food and water intake, relative organ weights, hematological and biochemical parameters, and histopathological examinations of the liver and kidneys were performed. HPLC-DAD analysis identified seven major phenolic compounds, namely catechin, chlorogenic acid, caffeic acid, vanillin, p-coumaric acid, quercetin, and kaempferol. No mortality, behavioral abnormalities, or treatment-related clinical signs were observed during either the acute or repeated-dose studies. The extract produced no significant alterations in body weight gain, food and water consumption, relative organ weights, liver and kidney histology, or most hematological and biochemical parameters. A significant reduction in serum total cholesterol and triglyceride levels was observed in treated animals, while platelet counts were significantly reduced only in female mice receiving 1000 mg/kg/day. Under the experimental conditions employed, the hydroethanolic extract of Cannabis sativa L. seeds exhibited a favorable oral safety profile, with an estimated LD50 greater than 5000 mg/kg. These findings support the traditional use and potential nutraceutical applications of Cannabis sativa seeds and provide a scientific basis for further pharmacological investigations and long-term safety studies.

  • Open Access

    In Vitro Digestive-Enzyme Inhibition and Antiglycation Activity of Cannabis sativa L. Essential Oil: Experimental Evaluation and Molecular Docking Analysis

    by Rafik El-Mernissi, Naoual El Menyiy, Rhizlan Abdnim, Oumayma Sayah, Yahya El-Mernissi, Aziz Zouhri, Mohamed Chebaibi, Moneerah J. Alqahtani, Jawaher H. Alqahtani, Joe Miantezila Basilua, et al.

    Aim of the Study: The aim of this study was to characterize the volatile phytochemical composition of Cannabis sativa L. essential oil (CSEO) and evaluate its in vitro inhibitory activity against selected digestive enzymes and its antiglycation activity. Molecular docking and ADMET analyses were additionally performed to explore the possible interactions and predicted pharmacokinetic properties of the major identified constituents. Materials and Methods: The chemical composition of CSEO was characterized by Gas Chromatography–Mass Spectrometry (GC-MS). Its in vitro inhibitory activity was evaluated against α-amylase, α-glucosidase, and pancreatic lipase, while its antiglycation activity was assessed by monitoring the formation of glycation products at different stages of the glycation process. Molecular docking simulations were performed to investigate the potential interactions of major identified terpenes with the active sites of the investigated enzymes. In addition, ADME analysis was conducted to predict selected pharmacokinetic and drug-likeness properties of the major constituents. Results: gc-ms analysis revealed a complex terpenoid profile, with β-caryophyllene as the major constituent, followed by selina-3,7(11)-diene (8.00%), cubenol (6.62%), γ-eudesmol (6.57%), epiglobulol (6.04%), and valencene (5.80%). CSEO showed significant in vitro inhibitory activity against α-amylase, α-glucosidase, and pancreatic lipase. The essential oil also exhibited antiglycation activity, with inhibition observed at different stages of glycation-product formation. Molecular docking analysis indicated that several major sesquiterpenes could interact with the investigated enzyme targets through different binding interactions. ADME analysis provided predicted pharmacokinetic and drug-likeness profiles for the major constituents. Conclusions: The findings demonstrate that Cannabis sativa L. essential oil possesses in vitro digestive-enzyme inhibitory and antiglycation activities. The docking results provide molecular-level insights into possible interactions between major essential-oil constituents and the investigated enzyme targets. These findings support further investigation of CSEO and its major constituents using appropriate in vivo and mechanistic studies to determine their biological relevance and potential applications.

  • Open Access

    Biological Activities and In Silico Molecular Docking of an Aqueous Extract of Nigella sativa L. Seeds: A Focus on Antioxidant, Cytotoxic, and Diuretic Effects

    by Otmane Zouirech, Rafik El-Mernissi, Mohamed Amine el Hajjaji, Marouane Takie, Mohammed Bouslamti, Abdelkrim Agour, Jawaher H. Alqahtani, Moneerah J. Alqahtani, Naoufal El Hachlafi, Joe Miantezila Basilua, et al.

    Background: Nigella sativa L. is a medicinal plant widely recognized for its diverse pharmacological properties. This study aimed to evaluate the antioxidant, diuretic, and cytotoxic effects of an aqueous seed extract and its effects on selected biochemical parameters in rats. The pharmacokinetic potential of identified bioactive compounds was also investigated in silico. Methods: The aqueous extract was prepared by maceration. Antioxidant activity was assessed using DPPH, reducing power, and total antioxidant capacity (TAC) assays. We evaluated the diuretic effect in vivo in Wistar rats by measuring urinary concentrations of Na+, K+, Cl−, and creatinine, using furosemide as a reference drug. Cytotoxicity was assessed in splenocytes and thymocytes. We analyzed seven identified compounds in silico for physicochemical properties, Lipinski compliance, intestinal absorption, cytochrome P450 inhibition, and blood–brain barrier permeability. Results: The extract showed significant antioxidant activity, with a DPPH IC50 of 0.254 ± 0.002 mg/mL and a TAC of 125.01 ± 4.220 mg AAE/g. It significantly increased urinary electrolyte and urinary concentration, indicating a diuretic effect lower than that of furosemide. Plasma analyses showed decreased electrolyte concentrations and increased creatinine levels. Cell viability exceeded 90%, indicating no significant cytotoxicity. Most compounds complied with Lipinski’s rule of five and showed favorable predicted intestinal absorption, with limited cytochrome P450 inhibition. Several compounds were predicted to cross the blood–brain barrier. Conclusions: The aqueous extract of N. sativa demonstrated antioxidant and diuretic activities without significant cytotoxicity. These findings support its pharmacological potential and warrant further investigation of its mechanisms of action and therapeutic relevance.

  • Open Access

    Integrated Computational Study Prioritizes Drug-like Para-Flavonoids as Candidate SARS-CoV-2 Mpro Inhibitors

    by Jawaher H. Alqahtani, Mohammed Ouachekradi, Bahia Abdelfattah, Amal Elrherabi, Moneerah J. Alqahtani, Joe Miantezila Basilua, Oussama Khibech, Mohamed Bouhrim

    Emerging SARS-CoV-2 variants highlight the need for orally active, low-toxicity antivirals. We designed seven para-substituted flavonoid hybrids (M1–M7) against the main protease (Mpro). In silico ADME filtering revealed zero Lipinski, Veber, or Ghose violations, a SwissADME bioavailability score of 0.55, and selected favorable predicted absorption and transporter endpoints relative to lopinavir, without implying measured pharmacokinetic superiority. ProTox-III indicated that amino and nitro substitution increased predicted genotoxicity liabilities, whereas cyano and methoxy substitution reduced selected endocrine-related signals. AutoDock Vina docking to Mpro (PDB 9C8Q; redocking RMSD 0.316 Å) ranked the nitro analogue M6 first among the designed compounds (−8.1 kcal mol−1), with contacts involving His41 and neighboring active-site residues. During the 100 ns GROMACS simulations, the protein backbone remained stable, whereas M6 adopted a late reoriented pose that was retained in the active-site region and supported by late-window per-residue energetic contributions. DFT calculations at the B3LYP/6-311G(d,p) level identified the narrowest HOMO-LUMO gap (3.44 eV) and highest electrophilicity (ω = 6.2 eV) for M6. Overall, M6 is prioritized as a computational lead requiring Mpro inhibition, antiviral, and cytotoxicity validation.

  • Open Access

    Phytochemical Characterization Using HPLC-DAD, Antiglycation Effect at Multiple Stages, Anti-Inflammatory and Analgesic Activities of Solanum elaeagnifolium Cav: Experimental and Computational Studies

    by Mohammed Bouslamti, Rhizlan Abdnim, Rafik El-Mernissi, Otmane Zouirech, Salah-Eddine Chebaibi, Moneerah J. Alqahtani, Jawaher H. Alqahtani, Joe Miantezila Basilua, Lhoussain Hajji, Naoufal El Hachlafi, et al.

    Solanum elaeagnifolium has been utilized for its analgesic, anti-inflammatory, and antioxidant properties to treat a range of conditions, including pain and inflammation. It possesses antibacterial, insecticidal, and molluscicidal properties as well. To investigate the pharmacological potential of the S. elaeagnifolium extract, in vitro, in vivo, and in silico studies were used. Albumin denaturation, heat-induced anti-haemolytic action, and lipooxygenase inhibition were the three techniques used to test anti-inflammatory effectiveness. The phenolic chemicals utilized were identified through the use of high-performance liquid chromatography (HPLC). The effectiveness of the extract in lowering problems connected to diabetes was further evaluated by evaluating fructosamines, carbonyl groups, and β-amyloid formations in albumin glycation. Regarding in vivo studies, the Writhing test and the tail flick test were the two techniques used to evaluate analgesic activity. For docking analysis, we used the following identifiers: cyclooxygenase (PDB ID: 6COX), lipooxygenase (PDB ID: 3V99) and VC1 domain of the receptor for advanced glycation products (PDB ID: 7LMW). The most prevalent phenolic chemicals, according to HPLC analysis, were 3,4-dihydroxybenzoic acid (4.78%), caffeic acid (1.28%), gallic acid (8.18%), ursolic acid (2.6%), syringic acid (1.78%), quercetin (24.09%), catechin (6.67%), and p-coumaric acid (20.49%). Significant suppression of albumin glycation and fructosamine production was demonstrated by the extract, indicating that it may help lessen difficulties associated with diabetes. Furthermore, the extract demonstrated a strong anti-inflammatory impact, with an IC50 of 146 ± 1.17 μg/mL for lipooxygenase inhibition, 87.64 ± 5.35 μg/mL for anti-haemolytic action, and 86.94 ± 1.63 μg/mL for albumin denaturation inhibition. A similar analgesic effect to those of analgesic medications was also demonstrated by SEFE extract. Reinforcing the relevance of the observed effects, the in silico study of the tested activities validated these findings. These findings indicate significant pharmacological promise in the management of diabetes consequences, including inflammation and protein glycation, as well as an analgesic.

  • Open Access

    Sandaracopimaric acid against the MAO-B/LRRK2 axis in Parkinson’s disease

    by Oussama Khibech, Amal Elrherabi, Loubna Kharchoufa, Hassan Zrouri, Moneerah J. Alqahtani, Jawaher H. Alqahtani, Joe Miantezila Basilua, Mohamed Bouhrim, Challioui Allal

    Parkinson’s disease lacks disease-modifying therapies; MAO-B inhibition remains a symptomatic standard, whereas LRRK2 kinase is a genetically validated Parkinson’s disease target. Here, the resin-acid diterpene sandaracopimaric acid (SCP) was evaluated as a CNS-oriented, hypothesis-generating scaffold rather than as a validated inhibitor. SwissADME predicted high gastrointestinal absorption, blood-brain barrier permeation and non-substrate behavior toward P-gp, with low aqueous solubility as the main developability limitation; ProTox-III suggested low acute oral toxicity (LD 50 approximately 20,000 mg·kg⁻¹; class 6). Redocking-validated docking to MAO-B (2V5Z; RMSD = 1.068 Å), LRRK2 (8FO7; RMSD = 1.693 Å), along with a complementary MAO-A selectivity counter-screen (2Z5X; RMSD = 0.270 Å) supported an MAO-B-favouring profile for SCP (-7.9 kcal·mol⁻¹) compared with LRRK2 (-6.9 kcal·mol⁻¹) and MAO-A (-6.2 kcal·mol⁻¹). In 100-ns GROMACS simulations, SCP remained more compactly retained in MAO-B than in LRRK2. MM/GBSA and PCA further supported a more favorable, single-basin MAO-B recognition pattern, whereas LRRK2 displayed a more solvent-exposed and flexible regime. Overall, SCP stands out computationally as an MAO-B-preferring natural scaffold ripe for experimental follow-up, where MAO-A/B enzymatic selectivity testing and LRRK2 kinase assays will serve to validate its true therapeutic viability.

  • Open Access

    Phytochemical characterization, molecular docking, and protective efficacy of Cleome droserifolia against cisplatin-induced testicular toxicity

    by Moneerah J. Alqahtani, Suzy A. El-Sherbeni, Walaa A. Negm, Engy Elekhnawy, Sarah Ibrahim, Ismail A. Hussein, Abdullah R. Alanzi, Rehab Ahmed, Marwa Balaha, Aya H. El-Kadem


  • Nasal In situ gel of zolmitriptan loaded GMO nanoparticles for effective migraine treatment: In vitro and in vivo assessment

    by Muhammad Ilyas, Rashna Mirza, Shefaat Ullah Shah, Asim Ur Rehman, Noor Ullah, Sajid Ali, Salman Khan, Abdullah R. Alanzi, Moneerah J. Alqahtani, Jawaher H. Alqahtani, et al.